Skyhawk Therapeutics
Maggie Beaudoin serves as the VP of Finance at Skyhawk Therapeutics since March 2024, bringing extensive financial leadership experience from previous roles as VP of Finance at Verve Therapeutics and Sr. Director of FP&A at AGTC. With a strong background in finance and accounting, Maggie has held significant positions including Consulting Manager at Bullpen Financial, Director of Finance at inVentiv Health, and Director in Transaction Services at PwC. Additional experience encompasses corporate development at Bottomline Technologies, finance leadership at Fisher Scientific, CFO roles at Navtronics, Inc. and Advanced Video Communications, Inc. Maggie Beaudoin holds a Bachelor of Arts in Economics from the University of Massachusetts Amherst.
This person is not in any teams
Skyhawk Therapeutics
1 followers
At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.